Treatment with abiraterone significantly improves survival in advanced prostate cancer

Currently, the medication abiraterone is approved for treatment of men with prostate cancer that has spread beyond the prostate gland and nearby lymph nodes. But a study found that men who received the drug at earlier stages (before the cancer had spread) in combination with another type of treatment were more likely to live longer than those who received only the control treatment.